Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children

Figure 1

(a) Study design flowchart showing the number of children included for the final analysis to assess the effect of praziquantel treatment efficacy 12 weeks after treatment. Participants who preferred not to receive treatment but voluntarily remained in the study at 12 weeks were utilized as untreated controls. (b) Study design flowchart to assess the effect of praziquantel 12 months after treatment.

(a)

(b)